NLS Pharmaceutics Ltd (NLSP)
3.365
+0.08
(+2.28%)
USD |
NASDAQ |
Nov 21, 16:00
3.17
-0.20
(-5.79%)
Pre-Market: 20:00
NLS Pharmaceutics Shareholders Equity (Quarterly): -9.268M for June 30, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | -9.268M |
| June 30, 2024 | -9.268M |
| December 31, 2023 | -8.834M |
| June 30, 2023 | -4.287M |
| June 30, 2023 | -4.287M |
| December 31, 2022 | 3.281M |
| June 30, 2022 | -4.042M |
| June 30, 2022 | -4.042M |
| December 31, 2021 | 0.5424M |
| Date | Value |
|---|---|
| June 30, 2021 | 4.249M |
| June 30, 2021 | 4.249M |
| December 31, 2020 | -8.984M |
| June 30, 2020 | -7.334M |
| June 30, 2020 | -7.334M |
| December 31, 2019 | -6.171M |
| June 30, 2019 | -4.197M |
| June 30, 2019 | -4.197M |
| December 31, 2018 | -8.814M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-9.268M
Minimum
Jun 2024
4.249M
Maximum
Jun 2021
-4.102M
Average
-4.287M
Median
Jun 2023
Shareholders Equity (Quarterly) Benchmarks
| AC Immune SA | 154.72M |
| CRISPR Therapeutics AG | 1.940B |
| Addex Therapeutics Ltd | 14.07M |
| Molecular Partners AG | 164.96M |
| MoonLake Immunotherapeutics | 488.20M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.194M |
| Total Liabilities (Quarterly) | 10.46M |